Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance

OBJECTIVE: Paraganglioma (PGL) and pheochromocytoma (PCC) are rare neuroendocrine tumors that were considered to be predominantly sporadic. However, with the identification of novel susceptibility genes over the last decade, it is currently estimated that up to 40% of cases can occur in the context...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Ana Milena, Soares, Diogo Cordeiro, Costa, Alexandre André Balieiro, Pereira, Daniele Paixão, Achatz, Maria Isabel, Formiga, Maria Nirvana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528659/
https://www.ncbi.nlm.nih.gov/pubmed/31365623
http://dx.doi.org/10.20945/2359-3997000000145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528659/
https://www.ncbi.nlm.nih.gov/pubmed/31365623
http://dx.doi.org/10.20945/2359-3997000000145

Ejemplares similares